|
Decitabine 20 mg/m²/day for 5 days Clinical Trials
1 actively recruiting trial across 1 location
Pipeline
Phase 2: 1
Top Sponsors
- The Methodist Hospital Research Institute1
Indications
- Acute Myeloid Leukaemia (AML)1
- Acute Myeloid Leukemia (AML)1
- Cancer1
Houston, Texas1 trial
Efficacy of Hypomethylating Agents vs. Intensive Chemotherapy in Acute Myeloid Leukemia Using 5hmC as a Blood-Based Minimal Residual Disease Marker
Houston Methodist Neal Cancer Center
Phase 2
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.